All products / DC11512
Acrizanib
Pack sizes and prices
| Pack size | Price |
|---|---|
| 100 mg | $950 USDRequest a quote → |
| 250 mg | $1,700 USDRequest a quote → |
| 1 g | $3,400 USDRequest a quote → |
In stock. Contact our team for lead time, shipping and final quotation.
Product overview
Acrizanib is a VEGFR-2 inhibitor, with an IC50 of 17.4 nM for BaF3-KDR.
For research use only. Results depend on experimental conditions and do not constitute a performance guarantee.
Identity and specifications
| Catalog number | DC11512 |
|---|---|
| Product name | Acrizanib |
| CAS | 1229453-99-9 |
| Molecular formula | C20H18F3N7O2 |
| Molecular weight | 445.3978 |
| Purity | >98% |
| SMILES | FC(C1=C([H])C(=NN1C([H])([H])[H])N([H])C(N1C([H])=C([H])C2C([H])=C(C([H])=C([H])C1=2)OC1C([H])=C(C([H])([H])N([H])C([H])([H])[H])N=C([H])N=1)=O)(F)F |
Source-listed specifications; the batch COA applies.
Source and product documents
The supplier source is linked below. Contact us for COA, SDS and batch-specific documents.
DC Chemicals — Acrizanib (DC11512)Source references
Rat ocular PK studies with Acrizanib shows a distinctly different profile from that observed with compound 25. While prolonged exposure is once again evident in the PEC, the AUC ratio to the level of Acrizanib in plasma is markedly increased (>21000-fold higher exposure in the PEC than plasma on day 11). Furthermore, unlike 25, Acrizanib also afford much improved retina to plasma AUC exposure ratio after 10 days of dosing (598× for Acrizanib vs 0.8× for 25)[1].
